CHEK2 1100delC and male breast cancer in the Netherlands
Authors:
- 31 August 2008
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 116 (2) , 397-400
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- BRCA1/2 mutation analysis in male breast cancer families from North West EnglandFamilial Cancer, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- Large genomic BRCA2 rearrangements and male breast cancerCancer Detection Prevention, 2006
- Male breast cancerThe Lancet, 2006
- Interindividual Variation in Nucleotide Excision Repair Genes and Risk of Endometrial CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 StudiesThe American Journal of Human Genetics, 2004
- CHEK2*1100delC and male breast cancer risk in IsraelInternational Journal of Cancer, 2003
- Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancersInternational Journal of Cancer, 2003
- CHEK2 1100delC is not a risk factor for male breast cancer populationInternational Journal of Cancer, 2003
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002